Drugs / Betula Verrucosa allergen extract
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00535639 | Oct → Dec 2007 | allergic disease | ALK-Abelló A/S | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02527187 | Sep 2015 → Apr 2016 | immune system disorder | Inmunotek S.L. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Betula verrucosa allergen extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02527187 ↗ |
| Route | Topical | “tested by administration onto skin” NCT02527187 ↗ |